We’ve been bringing new perspectives
to life science commercialization since 2008.
Over their careers and as consultants, our team has collectively launched 42 products in 32 therapeutic areas, delivering over $20 billion in annual peak revenue.
Our three principals work in conjunction with 20+ team members to provide you unparalleled experiential breadth. We’re industry veterans. We’ve advised pharmaceutical companies both large and small, launched fledgling biotech organizations’ first successful products and nurtured companies from Pre-IND all the way to FDA approval. Each of these hundreds of experiences has added invaluable perspective to our work while leaving our enthusiasm intact.
For us, it is about giving clients an edge. We do this not by using templates as answers, but by analyzing your asset in light of the competition and providing strategic solutions to address your unique business needs.
Jennifer Filbey, PhD
Vicki Morgan, MBA
Sarah A. Murchison, MHA